NovoCure Ltd (NVCR)
16.50
+0.36
(+2.26%)
USD |
NASDAQ |
May 10, 16:00
16.50
0.00 (0.00%)
After-Hours: 19:09
NovoCure Price to Book Value: 4.940 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 4.830 |
| May 08, 2024 | 4.800 |
| May 07, 2024 | 4.651 |
| May 06, 2024 | 4.656 |
| May 03, 2024 | 4.426 |
| May 02, 2024 | 4.249 |
| May 01, 2024 | 3.815 |
| April 30, 2024 | 3.665 |
| April 29, 2024 | 3.833 |
| April 26, 2024 | 3.784 |
| April 25, 2024 | 3.662 |
| April 24, 2024 | 3.695 |
| April 23, 2024 | 3.610 |
| April 22, 2024 | 3.542 |
| April 19, 2024 | 3.620 |
| April 18, 2024 | 3.608 |
| April 17, 2024 | 3.608 |
| April 16, 2024 | 3.731 |
| April 15, 2024 | 3.809 |
| April 12, 2024 | 4.063 |
| April 11, 2024 | 4.228 |
| April 10, 2024 | 4.378 |
| April 09, 2024 | 4.456 |
| April 08, 2024 | 4.246 |
| April 05, 2024 | 4.114 |
| Date | Value |
|---|---|
| April 04, 2024 | 4.279 |
| April 03, 2024 | 4.318 |
| April 02, 2024 | 4.309 |
| April 01, 2024 | 4.638 |
| March 31, 2024 | |
| March 28, 2024 | 4.618 |
| March 27, 2024 | 4.325 |
| March 26, 2024 | 3.861 |
| March 25, 2024 | 3.900 |
| March 22, 2024 | 3.903 |
| March 21, 2024 | 4.121 |
| March 20, 2024 | 4.027 |
| March 19, 2024 | 4.000 |
| March 18, 2024 | 4.083 |
| March 15, 2024 | 4.130 |
| March 14, 2024 | 4.316 |
| March 13, 2024 | 4.378 |
| March 12, 2024 | 4.517 |
| March 11, 2024 | 4.724 |
| March 08, 2024 | 4.886 |
| March 07, 2024 | 5.108 |
| March 06, 2024 | 4.919 |
| March 05, 2024 | 4.816 |
| March 04, 2024 | 4.854 |
| March 01, 2024 | 4.801 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.021
Minimum
Nov 10 2023
62.69
Maximum
Jun 23 2021
26.55
Average
23.98
Median
Price to Book Value Benchmarks
| AtriCure Inc | 2.364 |
| NeuroMetrix Inc | 0.4409 |
| Repligen Corp | 4.730 |
| Teleflex Inc | 2.134 |
| Perspective Therapeutics Inc | 13.66 |
Price to Book Value Related Metrics
| PS Ratio | 3.352 |
| PEG Ratio | -0.2598 |
| Price | 16.50 |
| Earnings Yield | -10.97% |
| Market Cap | 1.775B |
| PEGY Ratio | -0.2598 |